A phase II study of epirubicin in breast cancer.
el Mawla NG, Hamza MR, el Khodari A, Khaled H, Gaafar R, el Zawahry H, abdel Wareth A, Dardir MD, Habboubi N.
el Mawla NG, et al. Among authors: gaafar r.
Anticancer Drugs. 1991 Aug;2(4):371-4. doi: 10.1097/00001813-199108000-00006.
Anticancer Drugs. 1991.
PMID: 1797193
Clinical Trial.